Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
2,320
Value
$209.8K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of EW by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,320$209.8K<0.1%−110−4.5%ReducedHolders
Q1 20262,430$194.6K<0.1%+285+13.3%AddedHolders
Q4 20252,145$182.8K<0.1%−133−5.8%ReducedHolders
Q3 20252,278$177.1K<0.1%+122+5.7%AddedHolders
Q2 20252,156$168.6K<0.1%+2,156NewHolders
Q1 20250$00.0%−2,137−100.0%Sold outHolders
Q4 20242,137$158.2K<0.1%−1,209−36.1%ReducedHolders
Q3 20243,346$220.8K<0.1%−17,777−84.2%ReducedHolders
Q2 202421,123$1.95M0.1%−1,583−7.0%ReducedHolders
Q1 202422,706$2.17M0.1%−1,514−6.3%ReducedHolders
Q4 202324,220$1.85M0.1%+8,064+49.9%AddedHolders
Q3 202316,156$1.12M<0.1%+274+1.7%AddedHolders
Q2 202315,882$1.50M0.1%+1,242+8.5%AddedHolders
Q1 202314,640$1.21M0.1%+220+1.5%AddedHolders
Q4 202214,420$1.08M0.1%−14,001−49.3%ReducedHolders
Q3 202228,421$2.35M0.1%−609−2.1%ReducedHolders
Q2 202229,030$2.77M0.1%−145−0.5%ReducedHolders
Q1 202229,175$3.43M0.1%+3,158+12.1%AddedHolders
Q4 202126,017$3.37M0.1%−4,029−13.4%ReducedHolders
Q3 202130,046$3.40M0.1%+16,956+129.5%AddedHolders
Q2 202113,090$1.36M0.1%+312+2.4%AddedHolders
Q1 202112,778$1.07M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.